Literature DB >> 193441

Susceptibility of Clostridium perfringens isolated from human infections to twenty antibiotics.

J D Schwartzman, L B Reller, W L Wang.   

Abstract

The proper choice of antibiotic for Clostridium perfringens infections in patients allergic to penicillin is not clear; the usual recommendations and recent in vitro studies disagree. We tested the susceptibility of 57 strains of C. perfringens to eight penicillins, seven cephalosporins, two tetracyclines, clindamycin, chloramphenicol, and rifampin by the agar dilution method. All strains were inhibited by (per milliliter) 4 mug or less of any of the penicillins, chloramphenicol, or clindamycin and 8 mug or less of any of the cephalosporins tested. Penicillin G and amoxicillin inhibited all strains at 0.12 mug or less per ml. Only 54% of the strains were inhibited by 1 mug of tetracycline per ml. Penicillin G remains the drug of first choice for infections with C. perfringens; it need not be added to a regimen containing a penicillinase-resistant penicillin given parenterally in high doses. The cephalosporins should be considered as alternative drugs for penicillin-allergic patients. Clindamycin and chloramphenicol are also effective. Tetracyclines cannot be depended upon in clostridial infections without in vitro testing, which is impracticable for initial empirical therapy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 193441      PMCID: PMC352052          DOI: 10.1128/AAC.11.4.695

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Clostridial gas gangrene and septicemia in four patients with leukemia.

Authors:  D R BOGGS; E FREI; L B THOMAS
Journal:  N Engl J Med       Date:  1958-12-25       Impact factor: 91.245

Review 2.  Gas gangrene.

Authors:  L Weinstein; M A Barza
Journal:  N Engl J Med       Date:  1973-11-22       Impact factor: 91.245

3.  Standardized antimicrobial disc susceptibility testing of anaerobic bacteria: in vitro susceptibility of Clostridium perfringens to nine antibiotics.

Authors:  F L Sapico; Y Y Kwok; V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1972-10       Impact factor: 5.191

4.  The susceptibility of Clostridium perfringens type A to cephalosporin C antibiotics in vitro.

Authors:  W H Traub
Journal:  Chemotherapy       Date:  1971       Impact factor: 2.544

5.  Clostridium welchii resistance to tetracycline.

Authors:  F R Johnstone; W H Cockcroft
Journal:  Lancet       Date:  1968-03-30       Impact factor: 79.321

6.  Antibiotic susceptibility of Clostridium species isolated from human infections.

Authors:  K Dornbusch; C E Nord; A Dahlbäck
Journal:  Scand J Infect Dis       Date:  1975

7.  The in vitro spectrum of the cephalosporins.

Authors:  J A Washington
Journal:  Mayo Clin Proc       Date:  1976-04       Impact factor: 7.616

8.  In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens.

Authors:  W J Martin; M Gardner; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

9.  Postoperative clostridial infections in Britain.

Authors:  M T Parker
Journal:  Br Med J       Date:  1969-09-20

10.  Effect of several components of anaerobic incubation on antibiotic susceptibility test results.

Authors:  J E Rosenblatt; F Schoenknecht
Journal:  Antimicrob Agents Chemother       Date:  1972-05       Impact factor: 5.191

View more
  5 in total

1.  Isolation and characterization of multiply antibiotic-resistant Clostridum perfringens strains from porcine feces.

Authors:  J I Rood; E A Maher; E B Somers; E Campos; C L Duncan
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

2.  Effect of antibiotics on toxin production and viability of Clostridium perfringens.

Authors:  D L Stevens; K A Maier; J E Mitten
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

3.  Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens.

Authors:  D L Stevens; B M Laine; J E Mitten
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

Review 4.  Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-01       Impact factor: 9.546

Review 5.  Ticarcillin: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.